APO Research
Talk to an analyst

APO RESEARCH · REPORT

Finasteride

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Finasteride Market Analysis and Forecast 2026-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchFinasteride Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Finasteride Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Finasteride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Finasteride Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Finasteride Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Finasteride market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Finasteride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Finasteride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Finasteride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Finasteride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Finasteride include Teva Pharmaceuticals, Sandoz, Shandong Renhetang Pharmaceutical, Merck, Zhejiang CONBA Pharmaceutical, Henan Topfond, Guangdong Eashu Pharmacetical, RelonChem and Dr. Reddy, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Finasteride, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Finasteride, also provides the sales of main regions and countries. Of the upcoming market potential for Finasteride, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Finasteride sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Finasteride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Finasteride sales, projected growth trends, production technology, application and end-user industry.

Finasteride Segment by Company

Teva Pharmaceuticals

Sandoz

Shandong Renhetang Pharmaceutical

Merck

Zhejiang CONBA Pharmaceutical

Henan Topfond

Guangdong Eashu Pharmacetical

RelonChem

Dr. Reddy

Cipla

Actavis

Accord Pharmaceuticals

Finasteride Segment by Type

1mg Tablet

5mg Tablet

Finasteride Segment by Application

Medical Uses

Application 2

Finasteride Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Finasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Finasteride in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Finasteride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Finasteride sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Finasteride Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 1mg Tablet Major Manufacturers Table 3. 5mg Tablet Major Manufacturers Table 4. Global Finasteride Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical Uses Major Manufacturers Table 6. Application 2 Major Manufacturers Table 7. Finasteride Industry Trends Table 8. Finasteride Industry Drivers Table 9. Finasteride Industry Opportunities and Challenges Table 10. Finasteride Industry Restraints Table 11. Global Finasteride Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Finasteride Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Finasteride Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Finasteride Revenue Market Share by Region (2021-2026) Table 15. Global Finasteride Revenue Market Share by Region (2027-2032) Table 16. Global Finasteride Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 17. Global Finasteride Sales by Region (2021-2026) & (tons) Table 18. Global Finasteride Sales by Region (2027-2032) & (tons) Table 19. Global Finasteride Sales Market Share by Region (2021-2026) Table 20. Global Finasteride Sales Market Share by Region (2027-2032) Table 21. Global Finasteride Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Finasteride Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Finasteride Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Finasteride Sales Market Share by Manufacturers (2021-2026) Table 25. Global Finasteride Sales Price (US$/kg) of Manufacturers (2021-2026) Table 26. Global Finasteride Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Finasteride Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Finasteride Manufacturers, Product Type & Application Table 29. Global Finasteride Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Finasteride by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Finasteride Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Finasteride Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Finasteride Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Finasteride Revenue Market Share by Type (2021-2026) Table 36. Global Finasteride Revenue Market Share by Type (2027-2032) Table 37. Global Finasteride Sales by Type 2021 VS 2025 VS 2032 (tons) Table 38. Global Finasteride Sales by Type (2021-2026) & (tons) Table 39. Global Finasteride Sales by Type (2027-2032) & (tons) Table 40. Global Finasteride Sales Market Share by Type (2021-2026) Table 41. Global Finasteride Sales Market Share by Type (2027-2032) Table 42. Global Finasteride Price by Type (2021-2026) & (US$/kg) Table 43. Global Finasteride Price by Type (2027-2032) & (US$/kg) Table 44. Global Finasteride Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Finasteride Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Finasteride Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Finasteride Revenue Market Share by Application (2021-2026) Table 48. Global Finasteride Revenue Market Share by Application (2027-2032) Table 49. Global Finasteride Sales by Application 2021 VS 2025 VS 2032 (tons) Table 50. Global Finasteride Sales by Application (2021-2026) & (tons) Table 51. Global Finasteride Sales by Application (2027-2032) & (tons) Table 52. Global Finasteride Sales Market Share by Application (2021-2026) Table 53. Global Finasteride Sales Market Share by Application (2027-2032) Table 54. Global Finasteride Price by Application (2021-2026) & (US$/kg) Table 55. Global Finasteride Price by Application (2027-2032) & (US$/kg) Table 56. Teva Pharmaceuticals Company Information Table 57. Teva Pharmaceuticals Business Overview Table 58. Teva Pharmaceuticals Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 59. Teva Pharmaceuticals Finasteride Product Portfolio Table 60. Teva Pharmaceuticals Recent Development Table 61. Sandoz Company Information Table 62. Sandoz Business Overview Table 63. Sandoz Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 64. Sandoz Finasteride Product Portfolio Table 65. Sandoz Recent Development Table 66. Shandong Renhetang Pharmaceutical Company Information Table 67. Shandong Renhetang Pharmaceutical Business Overview Table 68. Shandong Renhetang Pharmaceutical Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 69. Shandong Renhetang Pharmaceutical Finasteride Product Portfolio Table 70. Shandong Renhetang Pharmaceutical Recent Development Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Merck Finasteride Product Portfolio Table 75. Merck Recent Development Table 76. Zhejiang CONBA Pharmaceutical Company Information Table 77. Zhejiang CONBA Pharmaceutical Business Overview Table 78. Zhejiang CONBA Pharmaceutical Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio Table 80. Zhejiang CONBA Pharmaceutical Recent Development Table 81. Henan Topfond Company Information Table 82. Henan Topfond Business Overview Table 83. Henan Topfond Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Henan Topfond Finasteride Product Portfolio Table 85. Henan Topfond Recent Development Table 86. Guangdong Eashu Pharmacetical Company Information Table 87. Guangdong Eashu Pharmacetical Business Overview Table 88. Guangdong Eashu Pharmacetical Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. Guangdong Eashu Pharmacetical Finasteride Product Portfolio Table 90. Guangdong Eashu Pharmacetical Recent Development Table 91. RelonChem Company Information Table 92. RelonChem Business Overview Table 93. RelonChem Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. RelonChem Finasteride Product Portfolio Table 95. RelonChem Recent Development Table 96. Dr. Reddy Company Information Table 97. Dr. Reddy Business Overview Table 98. Dr. Reddy Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. Dr. Reddy Finasteride Product Portfolio Table 100. Dr. Reddy Recent Development Table 101. Cipla Company Information Table 102. Cipla Business Overview Table 103. Cipla Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. Cipla Finasteride Product Portfolio Table 105. Cipla Recent Development Table 106. Actavis Company Information Table 107. Actavis Business Overview Table 108. Actavis Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 109. Actavis Finasteride Product Portfolio Table 110. Actavis Recent Development Table 111. Accord Pharmaceuticals Company Information Table 112. Accord Pharmaceuticals Business Overview Table 113. Accord Pharmaceuticals Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 114. Accord Pharmaceuticals Finasteride Product Portfolio Table 115. Accord Pharmaceuticals Recent Development Table 116. North America Finasteride Revenue by Type (2021-2026) & (US$ Million) Table 117. North America Finasteride Revenue by Type (2027-2032) & (US$ Million) Table 118. North America Finasteride Sales by Type (2021-2026) & (tons) Table 119. North America Finasteride Sales by Type (2027-2032) & (tons) Table 120. North America Finasteride Sales Price by Type (2021-2026) & (US$/kg) Table 121. North America Finasteride Sales Price by Type (2027-2032) & (US$/kg) Table 122. North America Finasteride Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Finasteride Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Finasteride Sales by Application (2021-2026) & (tons) Table 125. North America Finasteride Sales by Application (2027-2032) & (tons) Table 126. North America Finasteride Sales Price by Application (2021-2026) & (US$/kg) Table 127. North America Finasteride Sales Price by Application (2027-2032) & (US$/kg) Table 128. North America Finasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Finasteride Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. North America Finasteride Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. North America Finasteride Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 132. North America Finasteride Sales by Country (2021-2026) & (tons) Table 133. North America Finasteride Sales by Country (2027-2032) & (tons) Table 134. North America Finasteride Sales Price by Country (2021-2026) & (US$/kg) Table 135. North America Finasteride Sales Price by Country (2027-2032) & (US$/kg) Table 136. United States Finasteride Revenue (2021-2032) & (US$ Million) Table 137. Canada Finasteride Revenue (2021-2032) & (US$ Million) Table 138. Mexico Finasteride Revenue (2021-2032) & (US$ Million) Table 139. Europe Finasteride Revenue by Type (2021-2026) & (US$ Million) Table 140. Europe Finasteride Revenue by Type (2027-2032) & (US$ Million) Table 141. Europe Finasteride Sales by Type (2021-2026) & (tons) Table 142. Europe Finasteride Sales by Type (2027-2032) & (tons) Table 143. Europe Finasteride Sales Price by Type (2021-2026) & (US$/kg) Table 144. Europe Finasteride Sales Price by Type (2027-2032) & (US$/kg) Table 145. Europe Finasteride Revenue by Application (2021-2026) & (US$ Million) Table 146. Europe Finasteride Revenue by Application (2027-2032) & (US$ Million) Table 147. Europe Finasteride Sales by Application (2021-2026) & (tons) Table 148. Europe Finasteride Sales by Application (2027-2032) & (tons) Table 149. Europe Finasteride Sales Price by Application (2021-2026) & (US$/kg) Table 150. Europe Finasteride Sales Price by Application (2027-2032) & (US$/kg) Table 151. Europe Finasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Finasteride Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Europe Finasteride Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Europe Finasteride Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 155. Europe Finasteride Sales by Country (2021-2026) & (tons) Table 156. Europe Finasteride Sales by Country (2027-2032) & (tons) Table 157. Europe Finasteride Sales Price by Country (2021-2026) & (US$/kg) Table 158. Europe Finasteride Sales Price by Country (2027-2032) & (US$/kg) Table 159. Germany Finasteride Revenue (2021-2032) & (US$ Million) Table 160. France Finasteride Revenue (2021-2032) & (US$ Million) Table 161. U.K. Finasteride Revenue (2021-2032) & (US$ Million) Table 162. Italy Finasteride Revenue (2021-2032) & (US$ Million) Table 163. Russia Finasteride Revenue (2021-2032) & (US$ Million) Table 164. Spain Finasteride Revenue (2021-2032) & (US$ Million) Table 165. Netherlands Finasteride Revenue (2021-2032) & (US$ Million) Table 166. Switzerland Finasteride Revenue (2021-2032) & (US$ Million) Table 167. Sweden Finasteride Revenue (2021-2032) & (US$ Million) Table 168. Poland Finasteride Revenue (2021-2032) & (US$ Million) Table 169. China Finasteride Revenue by Type (2021-2026) & (US$ Million) Table 170. China Finasteride Revenue by Type (2027-2032) & (US$ Million) Table 171. China Finasteride Sales by Type (2021-2026) & (tons) Table 172. China Finasteride Sales by Type (2027-2032) & (tons) Table 173. China Finasteride Sales Price by Type (2021-2026) & (US$/kg) Table 174. China Finasteride Sales Price by Type (2027-2032) & (US$/kg) Table 175. China Finasteride Revenue by Application (2021-2026) & (US$ Million) Table 176. China Finasteride Revenue by Application (2027-2032) & (US$ Million) Table 177. China Finasteride Sales by Application (2021-2026) & (tons) Table 178. China Finasteride Sales by Application (2027-2032) & (tons) Table 179. China Finasteride Sales Price by Application (2021-2026) & (US$/kg) Table 180. China Finasteride Sales Price by Application (2027-2032) & (US$/kg) Table 181. Asia Finasteride Revenue by Type (2021-2026) & (US$ Million) Table 182. Asia Finasteride Revenue by Type (2027-2032) & (US$ Million) Table 183. Asia Finasteride Sales by Type (2021-2026) & (tons) Table 184. Asia Finasteride Sales by Type (2027-2032) & (tons) Table 185. Asia Finasteride Sales Price by Type (2021-2026) & (US$/kg) Table 186. Asia Finasteride Sales Price by Type (2027-2032) & (US$/kg) Table 187. Asia Finasteride Revenue by Application (2021-2026) & (US$ Million) Table 188. Asia Finasteride Revenue by Application (2027-2032) & (US$ Million) Table 189. Asia Finasteride Sales by Application (2021-2026) & (tons) Table 190. Asia Finasteride Sales by Application (2027-2032) & (tons) Table 191. Asia Finasteride Sales Price by Application (2021-2026) & (US$/kg) Table 192. Asia Finasteride Sales Price by Application (2027-2032) & (US$/kg) Table 193. Asia Finasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Asia Finasteride Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Asia Finasteride Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Asia Finasteride Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 197. Asia Finasteride Sales by Country (2021-2026) & (tons) Table 198. Asia Finasteride Sales by Country (2027-2032) & (tons) Table 199. Asia Finasteride Sales Price by Country (2021-2026) & (US$/kg) Table 200. Asia Finasteride Sales Price by Country (2027-2032) & (US$/kg) Table 201. Japan Finasteride Revenue (2021-2032) & (US$ Million) Table 202. South Korea Finasteride Revenue (2021-2032) & (US$ Million) Table 203. India Finasteride Revenue (2021-2032) & (US$ Million) Table 204. Australia Finasteride Revenue (2021-2032) & (US$ Million) Table 205. Taiwan Finasteride Revenue (2021-2032) & (US$ Million) Table 206. Southeast Asia Finasteride Revenue (2021-2032) & (US$ Million) Table 207. SAMEA Finasteride Revenue by Type (2021-2026) & (US$ Million) Table 208. SAMEA Finasteride Revenue by Type (2027-2032) & (US$ Million) Table 209. SAMEA Finasteride Sales by Type (2021-2026) & (tons) Table 210. SAMEA Finasteride Sales by Type (2027-2032) & (tons) Table 211. SAMEA Finasteride Sales Price by Type (2021-2026) & (US$/kg) Table 212. SAMEA Finasteride Sales Price by Type (2027-2032) & (US$/kg) Table 213. SAMEA Finasteride Revenue by Application (2021-2026) & (US$ Million) Table 214. SAMEA Finasteride Revenue by Application (2027-2032) & (US$ Million) Table 215. SAMEA Finasteride Sales by Application (2021-2026) & (tons) Table 216. SAMEA Finasteride Sales by Application (2027-2032) & (tons) Table 217. SAMEA Finasteride Sales Price by Application (2021-2026) & (US$/kg) Table 218. SAMEA Finasteride Sales Price by Application (2027-2032) & (US$/kg) Table 219. SAMEA Finasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. SAMEA Finasteride Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. SAMEA Finasteride Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. SAMEA Finasteride Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 223. SAMEA Finasteride Sales by Country (2021-2026) & (tons) Table 224. SAMEA Finasteride Sales by Country (2027-2032) & (tons) Table 225. SAMEA Finasteride Sales Price by Country (2021-2026) & (US$/kg) Table 226. SAMEA Finasteride Sales Price by Country (2027-2032) & (US$/kg) Table 227. Brazil Finasteride Revenue (2021-2032) & (US$ Million) Table 228. Argentina Finasteride Revenue (2021-2032) & (US$ Million) Table 229. Chile Finasteride Revenue (2021-2032) & (US$ Million) Table 230. Colombia Finasteride Revenue (2021-2032) & (US$ Million) Table 231. Peru Finasteride Revenue (2021-2032) & (US$ Million) Table 232. Saudi Arabia Finasteride Revenue (2021-2032) & (US$ Million) Table 233. Israel Finasteride Revenue (2021-2032) & (US$ Million) Table 234. UAE Finasteride Revenue (2021-2032) & (US$ Million) Table 235. Turkey Finasteride Revenue (2021-2032) & (US$ Million) Table 236. Iran Finasteride Revenue (2021-2032) & (US$ Million) Table 237. Egypt Finasteride Revenue (2021-2032) & (US$ Million) Table 238. Key Raw Materials Table 239. Raw Materials Key Suppliers Table 240. Finasteride Distributors List Table 241. Finasteride Customers List Table 242. Research Programs/Design for This Report Table 243. Authors List of This Report Table 244. Secondary Sources Table 245. Primary Sources List of Figures Figure 1. Finasteride Image Figure 2. Global Finasteride Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Finasteride Market Size Share 2021 VS 2025 VS 2032 Figure 4. 1mg Tablet Image Figure 5. 5mg Tablet Image Figure 6. Global Finasteride Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Finasteride Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical Uses Image Figure 9. Application 2 Image Figure 10. Global Finasteride Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Finasteride Revenue (2021-2032) & (US$ Million) Figure 12. Global Finasteride Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Finasteride Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Finasteride Revenue Market Share by Region (2021-2032) Figure 15. Global Finasteride Sales (2021-2032) & (tons) Figure 16. Global Finasteride Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 17. Global Finasteride Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Finasteride Sales YoY (2021-2032) & (tons) Figure 19. Europe Finasteride Sales YoY (2021-2032) & (tons) Figure 20. China Finasteride Sales YoY (2021-2032) & (tons) Figure 21. Asia (Excluding China) Finasteride Sales YoY (2021-2032) & (tons) Figure 22. South America, Middle East and Africa Finasteride Sales YoY (2021-2032) & (tons) Figure 23. Global Finasteride Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Finasteride Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Finasteride Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Finasteride Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Finasteride Revenue Market Share by Type (2021-2032) Figure 29. Global Finasteride Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 30. Global Finasteride Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Finasteride Sales Market Share by Type (2021-2032) Figure 32. Global Finasteride Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Finasteride Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Finasteride Revenue Market Share by Application (2021-2032) Figure 35. Global Finasteride Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 36. Global Finasteride Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Finasteride Sales Market Share by Application (2021-2032) Figure 38. North America Finasteride Revenue Share by Type (2021-2032) Figure 39. North America Finasteride Sales Share by Type (2021-2032) Figure 40. North America Finasteride Revenue Share by Application (2021-2032) Figure 41. North America Finasteride Sales Share by Application (2021-2032) Figure 42. North America Finasteride Revenue Share by Country (2021-2032) Figure 43. North America Finasteride Sales Share by Country (2021-2032) Figure 44. Europe Finasteride Revenue Share by Type (2021-2032) Figure 45. Europe Finasteride Sales Share by Type (2021-2032) Figure 46. Europe Finasteride Revenue Share by Application (2021-2032) Figure 47. Europe Finasteride Sales Share by Application (2021-2032) Figure 48. Europe Finasteride Revenue Share by Country (2021-2032) Figure 49. Europe Finasteride Sales Share by Country (2021-2032) Figure 50. China Finasteride Revenue Share by Type (2021-2032) Figure 51. China Finasteride Sales Share by Type (2021-2032) Figure 52. China Finasteride Revenue Share by Application (2021-2032) Figure 53. China Finasteride Sales Share by Application (2021-2032) Figure 54. Asia Finasteride Revenue Share by Type (2021-2032) Figure 55. Asia Finasteride Sales Share by Type (2021-2032) Figure 56. Asia Finasteride Revenue Share by Application (2021-2032) Figure 57. Asia Finasteride Sales Share by Application (2021-2032) Figure 58. Asia Finasteride Revenue Share by Country (2021-2032) Figure 59. Asia Finasteride Sales Share by Country (2021-2032) Figure 60. SAMEA Finasteride Revenue Share by Type (2021-2032) Figure 61. SAMEA Finasteride Sales Share by Type (2021-2032) Figure 62. SAMEA Finasteride Revenue Share by Application (2021-2032) Figure 63. SAMEA Finasteride Sales Share by Application (2021-2032) Figure 64. SAMEA Finasteride Revenue Share by Country (2021-2032) Figure 65. SAMEA Finasteride Sales Share by Country (2021-2032) Figure 66. Finasteride Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Finasteride Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg Tablet
  • 5mg Tablet
Applications
  • Medical Uses
  • Application 2
Companies covered
  • Teva Pharmaceuticals
  • Sandoz
  • Shandong Renhetang Pharmaceutical
  • Merck
  • Zhejiang CONBA Pharmaceutical
  • Henan Topfond
  • Guangdong Eashu Pharmacetical
  • RelonChem
  • Dr. Reddy
  • Cipla
  • Actavis
  • Accord Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Finasteride Market by Type
  3. 1.2.1 Global Finasteride Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 1mg Tablet
  5. 1.2.3 5mg Tablet
  6. 1.3 Finasteride Market by Application
  7. 1.3.1 Global Finasteride Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical Uses
  9. 1.3.3 Application 2
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Finasteride Market Dynamics
  1. 2.1 Finasteride Industry Trends
  2. 2.2 Finasteride Industry Drivers
  3. 2.3 Finasteride Industry Opportunities and Challenges
  4. 2.4 Finasteride Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Finasteride Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Finasteride Revenue by Region
  3. 3.2.1 Global Finasteride Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Finasteride Revenue by Region (2021-2026)
  5. 3.2.3 Global Finasteride Revenue by Region (2027-2032)
  6. 3.2.4 Global Finasteride Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Finasteride Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Finasteride Sales by Region
  9. 3.4.1 Global Finasteride Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Finasteride Sales by Region (2021-2026)
  11. 3.4.3 Global Finasteride Sales by Region (2027-2032)
  12. 3.4.4 Global Finasteride Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Finasteride Revenue by Manufacturers
  2. 4.1.1 Global Finasteride Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Finasteride Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Finasteride Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Finasteride Sales by Manufacturers
  6. 4.2.1 Global Finasteride Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Finasteride Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Finasteride Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Finasteride Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Finasteride Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Finasteride Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Finasteride Manufacturers, Product Type & Application
  13. 4.7 Global Finasteride Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Finasteride Market CR5 and HHI
  16. 4.8.2 2025 Finasteride Tier 1, Tier 2, and Tier 3
5 Finasteride Market by Type
  1. 5.1 Global Finasteride Revenue by Type
  2. 5.1.1 Global Finasteride Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Finasteride Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Finasteride Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Finasteride Sales by Type
  6. 5.2.1 Global Finasteride Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Finasteride Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Finasteride Sales Market Share by Type (2021-2032)
  9. 5.3 Global Finasteride Price by Type
6 Finasteride Market by Application
  1. 6.1 Global Finasteride Revenue by Application
  2. 6.1.1 Global Finasteride Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Finasteride Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Finasteride Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Finasteride Sales by Application
  6. 6.2.1 Global Finasteride Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Finasteride Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Finasteride Sales Market Share by Application (2021-2032)
  9. 6.3 Global Finasteride Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceuticals
  2. 7.1.1 Teva Pharmaceuticals Company Information
  3. 7.1.2 Teva Pharmaceuticals Business Overview
  4. 7.1.3 Teva Pharmaceuticals Finasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceuticals Finasteride Product Portfolio
  6. 7.1.5 Teva Pharmaceuticals Recent Developments
  7. 7.2 Sandoz
  8. 7.2.1 Sandoz Company Information
  9. 7.2.2 Sandoz Business Overview
  10. 7.2.3 Sandoz Finasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sandoz Finasteride Product Portfolio
  12. 7.2.5 Sandoz Recent Developments
  13. 7.3 Shandong Renhetang Pharmaceutical
  14. 7.3.1 Shandong Renhetang Pharmaceutical Company Information
  15. 7.3.2 Shandong Renhetang Pharmaceutical Business Overview
  16. 7.3.3 Shandong Renhetang Pharmaceutical Finasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shandong Renhetang Pharmaceutical Finasteride Product Portfolio
  18. 7.3.5 Shandong Renhetang Pharmaceutical Recent Developments
  19. 7.4 Merck
  20. 7.4.1 Merck Company Information
  21. 7.4.2 Merck Business Overview
  22. 7.4.3 Merck Finasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck Finasteride Product Portfolio
  24. 7.4.5 Merck Recent Developments
  25. 7.5 Zhejiang CONBA Pharmaceutical
  26. 7.5.1 Zhejiang CONBA Pharmaceutical Company Information
  27. 7.5.2 Zhejiang CONBA Pharmaceutical Business Overview
  28. 7.5.3 Zhejiang CONBA Pharmaceutical Finasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio
  30. 7.5.5 Zhejiang CONBA Pharmaceutical Recent Developments
  31. 7.6 Henan Topfond
  32. 7.6.1 Henan Topfond Company Information
  33. 7.6.2 Henan Topfond Business Overview
  34. 7.6.3 Henan Topfond Finasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Henan Topfond Finasteride Product Portfolio
  36. 7.6.5 Henan Topfond Recent Developments
  37. 7.7 Guangdong Eashu Pharmacetical
  38. 7.7.1 Guangdong Eashu Pharmacetical Company Information
  39. 7.7.2 Guangdong Eashu Pharmacetical Business Overview
  40. 7.7.3 Guangdong Eashu Pharmacetical Finasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Guangdong Eashu Pharmacetical Finasteride Product Portfolio
  42. 7.7.5 Guangdong Eashu Pharmacetical Recent Developments
  43. 7.8 RelonChem
  44. 7.8.1 RelonChem Company Information
  45. 7.8.2 RelonChem Business Overview
  46. 7.8.3 RelonChem Finasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 RelonChem Finasteride Product Portfolio
  48. 7.8.5 RelonChem Recent Developments
  49. 7.9 Dr. Reddy
  50. 7.9.1 Dr. Reddy Company Information
  51. 7.9.2 Dr. Reddy Business Overview
  52. 7.9.3 Dr. Reddy Finasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Dr. Reddy Finasteride Product Portfolio
  54. 7.9.5 Dr. Reddy Recent Developments
  55. 7.10 Cipla
  56. 7.10.1 Cipla Company Information
  57. 7.10.2 Cipla Business Overview
  58. 7.10.3 Cipla Finasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Cipla Finasteride Product Portfolio
  60. 7.10.5 Cipla Recent Developments
  61. 7.11 Actavis
  62. 7.11.1 Actavis Company Information
  63. 7.11.2 Actavis Business Overview
  64. 7.11.3 Actavis Finasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Actavis Finasteride Product Portfolio
  66. 7.11.5 Actavis Recent Developments
  67. 7.12 Accord Pharmaceuticals
  68. 7.12.1 Accord Pharmaceuticals Company Information
  69. 7.12.2 Accord Pharmaceuticals Business Overview
  70. 7.12.3 Accord Pharmaceuticals Finasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Accord Pharmaceuticals Finasteride Product Portfolio
  72. 7.12.5 Accord Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Finasteride Market Size by Type
  2. 8.1.1 North America Finasteride Revenue by Type (2021-2032)
  3. 8.1.2 North America Finasteride Sales by Type (2021-2032)
  4. 8.1.3 North America Finasteride Price by Type (2021-2032)
  5. 8.2 North America Finasteride Market Size by Application
  6. 8.2.1 North America Finasteride Revenue by Application (2021-2032)
  7. 8.2.2 North America Finasteride Sales by Application (2021-2032)
  8. 8.2.3 North America Finasteride Price by Application (2021-2032)
  9. 8.3 North America Finasteride Market Size by Country
  10. 8.3.1 North America Finasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Finasteride Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Finasteride Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Finasteride Market Size by Type
  2. 9.1.1 Europe Finasteride Revenue by Type (2021-2032)
  3. 9.1.2 Europe Finasteride Sales by Type (2021-2032)
  4. 9.1.3 Europe Finasteride Price by Type (2021-2032)
  5. 9.2 Europe Finasteride Market Size by Application
  6. 9.2.1 Europe Finasteride Revenue by Application (2021-2032)
  7. 9.2.2 Europe Finasteride Sales by Application (2021-2032)
  8. 9.2.3 Europe Finasteride Price by Application (2021-2032)
  9. 9.3 Europe Finasteride Market Size by Country
  10. 9.3.1 Europe Finasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Finasteride Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Finasteride Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Finasteride Market Size by Type
  2. 10.1.1 China Finasteride Revenue by Type (2021-2032)
  3. 10.1.2 China Finasteride Sales by Type (2021-2032)
  4. 10.1.3 China Finasteride Price by Type (2021-2032)
  5. 10.2 China Finasteride Market Size by Application
  6. 10.2.1 China Finasteride Revenue by Application (2021-2032)
  7. 10.2.2 China Finasteride Sales by Application (2021-2032)
  8. 10.2.3 China Finasteride Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Finasteride Market Size by Type
  2. 11.1.1 Asia Finasteride Revenue by Type (2021-2032)
  3. 11.1.2 Asia Finasteride Sales by Type (2021-2032)
  4. 11.1.3 Asia Finasteride Price by Type (2021-2032)
  5. 11.2 Asia Finasteride Market Size by Application
  6. 11.2.1 Asia Finasteride Revenue by Application (2021-2032)
  7. 11.2.2 Asia Finasteride Sales by Application (2021-2032)
  8. 11.2.3 Asia Finasteride Price by Application (2021-2032)
  9. 11.3 Asia Finasteride Market Size by Country
  10. 11.3.1 Asia Finasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Finasteride Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Finasteride Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Finasteride Market Size by Type
  2. 12.1.1 SAMEA Finasteride Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Finasteride Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Finasteride Price by Type (2021-2032)
  5. 12.2 SAMEA Finasteride Market Size by Application
  6. 12.2.1 SAMEA Finasteride Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Finasteride Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Finasteride Price by Application (2021-2032)
  9. 12.3 SAMEA Finasteride Market Size by Country
  10. 12.3.1 SAMEA Finasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Finasteride Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Finasteride Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Finasteride Value Chain Analysis
  2. 13.1.1 Finasteride Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Finasteride Production Mode & Process
  6. 13.2 Finasteride Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Finasteride Distributors
  9. 13.2.3 Finasteride Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst